Ionotropic glutamate receptors (iGluRs) play a critical role in normal brain function and neurodegenerative diseases. Development of light-dependent compounds would enable studies of iGluRs within intact mammalian neural tissue, as light is noninvasive and can be applied with high spatiotemporal precision. Here we develop a potent photochromic antagonist that selectively targets the Ca2+ permeable
离子型谷
氨酸受体(iGluRs)在正常的脑功能和神经退行性疾病中起关键作用。光依赖性化合物的开发将使研究完整的哺乳动物神经组织内的iGluR成为可能,因为光是非侵入性的并且可以以高时空精度应用。在这里,我们开发了一种有效的光致变色拮抗剂,该拮抗剂选择性靶向靶向Ca 2+的
AMPA型iGuRs,从而为研究
AMPA型iGluRs对神经元活动的贡献提供了重要的工具。